Castle Biosciences (CSTL) EPS (Weighted Average and Diluted) (2018 - 2025)
Historic EPS (Weighted Average and Diluted) for Castle Biosciences (CSTL) over the last 8 years, with Q3 2025 value amounting to -$0.02.
- Castle Biosciences' EPS (Weighted Average and Diluted) fell 12500.0% to -$0.02 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.45, marking a year-over-year decrease of 31428.57%. This contributed to the annual value of $0.62 for FY2024, which is 12914.27% up from last year.
- As of Q3 2025, Castle Biosciences' EPS (Weighted Average and Diluted) stood at -$0.02, which was down 12500.0% from $0.15 recorded in Q2 2025.
- Castle Biosciences' 5-year EPS (Weighted Average and Diluted) high stood at $0.33 for Q4 2024, and its period low was -$1.1 during Q1 2023.
- In the last 5 years, Castle Biosciences' EPS (Weighted Average and Diluted) had a median value of -$0.25 in 2021 and averaged -$0.32.
- Per our database at Business Quant, Castle Biosciences' EPS (Weighted Average and Diluted) tumbled by 106666.67% in 2023 and then soared by 46423.02% in 2024.
- Castle Biosciences' EPS (Weighted Average and Diluted) (Quarter) stood at -$0.25 in 2021, then crashed by 216.0% to -$0.79 in 2022, then skyrocketed by 88.61% to -$0.09 in 2023, then soared by 464.23% to $0.33 in 2024, then plummeted by 106.1% to -$0.02 in 2025.
- Its EPS (Weighted Average and Diluted) was -$0.02 in Q3 2025, compared to $0.15 in Q2 2025 and -$0.9 in Q1 2025.